PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954593
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954593
The global organ preservation market was valued at USD 323.83 million in 2025 and is projected to grow to USD 368.65 million in 2026, reaching USD 684.06 million by 2034, registering a CAGR of 8.03% during the forecast period. North America dominated the global market with a 36.87% share in 2025.
Organ preservation refers to the medical and logistical processes that maintain the viability of donated organs from retrieval to transplantation. The primary objective is to minimize ischemic damage and ensure optimal graft function. Advancements in preservation technologies are enabling longer storage times, safer transportation, and improved transplant outcomes.
Market Dynamics
Market Drivers
One of the key drivers accelerating market growth is the rapid adoption of machine perfusion technologies. Regulatory approvals of advanced systems across various countries are further strengthening demand.
In October 2024, Health Canada approved the OrganOx metra System for liver transplantation, with commercial launch planned in 2025. Additionally, the increasing number of transplant procedures globally supports demand. According to GODT/IRODaT 2023 data, solid-organ transplants increased by 9-10% worldwide. India recorded approximately 18,378 transplants in 2023, reflecting significant growth over the past decade.
Market Restraints
Despite technological progress, high capital investment and operating costs restrict broader adoption. For instance, the OCS Heart Perfusion Set costs approximately USD 40,000 per use, while the reusable console costs about USD 240,000. Advanced transportation systems such as Paragonix SherpaPak cost between USD 9,000 and USD 17,000 per shipment. These costs limit accessibility, especially in developing regions.
Market Opportunities
Innovation in preservation solutions and oxygen carriers presents strong growth opportunities. Products such as HEMO2life (M101), an extracellular hemoglobin additive, improve oxygenation and reduce ischemic injury during storage. Clinical studies show improved graft function and reduced delayed graft function (DGF), supporting increasing adoption.
Market Challenges
A major challenge remains limited donor organ availability. In the U.S., over 100,000 patients remain on transplant waiting lists, while 48,149 transplants were performed in 2024. The supply-demand gap continues to restrict procedural volumes despite technological advances.
Market Trends
A significant trend shaping the market is the shift from Static Cold Storage (SCS) toward Hypothermic Machine Perfusion (HMP) and Normothermic Machine Perfusion (NMP). While SCS remains dominant due to simplicity and cost-effectiveness, machine perfusion technologies are gaining share due to improved graft survival and reduced complications such as DGF and early allograft dysfunction.
By Product Type
The preservation solutions & media segment held the largest share of 52.95% in 2026, driven by widespread application across organ types. The perfusion consumables & disposables segment is projected to grow at a CAGR of 13.1% through 2034.
By Preservation Technique
The Static Cold Storage (SCS) segment dominated the market and is expected to account for 52.44% share in 2026. However, the Normothermic Machine Perfusion (NMP) segment is projected to grow at a CAGR of 15.3% during the forecast period.
By Organ Type
The kidney segment led the market with a 50.53% share in 2026, supported by high transplant volumes and rising chronic kidney disease (CKD) prevalence. The heart segment is expected to grow at 13.4% CAGR through 2034.
By End User
Hospitals dominated the market with a 78.15% share in 2026, driven by high transplant procedure volumes and rapid adoption of advanced perfusion technologies. Organ Procurement Organizations (OPOs) are projected to grow at a CAGR of 9.2%.
Regional Analysis
North America
North America accounted for USD 119.4 million in 2025 and is projected to reach USD 136.99 million in 2026, maintaining market leadership due to strong transplant infrastructure and early adoption of advanced technologies.
Europe and Asia Pacific
Europe is projected to grow at a CAGR of 7.8% and recorded USD 70.1 million in 2025. Growth is driven by rising transplant procedures and supportive healthcare frameworks. Asia Pacific is also witnessing strong growth, supported by expanding transplant awareness and healthcare investments.
Latin America and Middle East & Africa
Latin America recorded USD 27.3 million in 2025, while GCC countries in the Middle East & Africa reached USD 9.8 million in 2025, driven by increasing organ failure cases and gradual improvements in transplant infrastructure.
Competitive Landscape
The market is semi-consolidated, with key players including TransMedics, XVIVO, Terumo Corporation, Getinge AB, and Organ Recovery Systems. These companies maintain leadership through strong product portfolios, strategic acquisitions, regulatory approvals, and global expansion initiatives.
Recent developments include FDA approvals, product launches, and acquisitions such as Getinge's acquisition of Paragonix Technologies in 2024 and OrganOx's FDA approval for air transport operation in 2025.
Conclusion
The global organ preservation market is set for steady expansion from USD 323.83 million in 2025 to USD 684.06 million by 2034, driven by technological advancements in machine perfusion, rising transplant volumes, and innovation in preservation solutions. While high equipment costs and donor shortages present challenges, increasing regulatory approvals, growing awareness, and expanding healthcare infrastructure across emerging markets are expected to sustain long-term growth. As machine perfusion technologies gain momentum over traditional static cold storage, the market is poised to witness transformative advancements through 2034.
Segmentation By Product Type, Preservation Technique, Organ Type, End User, and Region
By Product Type * Preservation Solutions & Media
By Preservation Technique * Static Cold Storage (SCS)
By Organ Type * Kidney
By End User * Hospitals
By Region * North America (By Product Type, Preservation Technique, Organ Type, End User, and Country)